
Kinesis Pharmaceuticals Private Limited
Pharmaceutical company manufacturing various dosage forms and representing other companies under specific agreements.
Pharmaceutical company manufacturing various dosage forms and representing other companies under specific agreements.
Kinesis Pharmaceuticals Private Limited (KPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 22 March 1994 and has a history of 31 years and one month. Its registered office is in Tiruvallur, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 2.00 Cr.
The company currently has active open charges totaling ₹0.60 M.
Arumugam Olaganathan, Viswanathan Shanmugasundaram, and Olaganathan Meenakshi serve as directors at the Company.
Tiruvallur, Tamil Nadu, India
+91-XXXXXXXXXX
U24231TN1994PTC027081
027081
Private Limited Indian Non-Government Company
22 Mar 1994
30 Sep 2024
31 Mar 2024
Unlisted
Roc Chennai
Kinesis Pharmaceuticals Private Limited offers a wide range of products and services, including Health Conditions, Fever.
Name | Designation | Appointment Date | Status |
---|---|---|---|
Arumugam Olaganathan ![]() | Director | 15-Mar-2010 | Current |
Viswanathan Shanmugasundaram ![]() | Additional Director | 01-Aug-2022 | Current |
Olaganathan Meenakshi ![]() | Additional Director | 27-Jan-2011 | Current |
Kinesis Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 15.45% decrease. The company also saw a substantial fall in profitability, with a 73.73% decrease in profit. The company's net worth Soared by an impressive increase of 25.46%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
Unlock access to Kinesis Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Viswanathan Shanmugasundaram is a mutual person
Viswanathan Shanmugasundaram is a mutual person
Arumugam Olaganathan is a mutual person
Viswanathan Shanmugasundaram is a mutual person
Arumugam Olaganathan and Olaganathan Meenakshi are mutual person
Viswanathan Shanmugasundaram is a mutual person
₹0.06 Cr
₹0
Date | Lender | Amount | Status |
---|---|---|---|
03 Jan 1998 | The Vysya Bank Limited | ₹0.50 M | Open |
16 Feb 1995 | Indian Overseas Bank | ₹0.10 M | Open |
Kinesis Pharmaceuticals has a workforce of 33 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Kinesis Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kinesis Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Kinesis Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Kinesis Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai.
Viswanathan Shanmugasundaram was appointed as a Additional Director was appointed as a Additional Director on 01 Aug 2022 & has been associated with this company since 2 years 9 months .
Olaganathan Meenakshi was appointed as a Additional Director was appointed as a Additional Director on 27 Jan 2011 & has been associated with this company since 14 years 3 months .
Arumugam Olaganathan was appointed as a Director was appointed as a Director on 15 Mar 2010 & has been associated with this company since 15 years 1 month .
A charge with The Vysya Bank Limited of Rs. 0.05 Cr registered on 03 Jan 1998 with Charge ID 90282973 was modified on 05 Jul 2004.
Kinesis Pharmaceuticals Private Limited was incorporated on 22 Mar 1994.
The authorized share capital of Kinesis Pharmaceuticals Private Limited is ₹ 5.00 Cr and paid-up capital is ₹ 2.00 Cr.
Currently 3 directors are associated with Kinesis Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Kinesis Pharmaceuticals Private Limited is No.87 96 Mohammed Hussain Colony Vivekanada Nagar Main Road Kolathur, India, Chennai, Tamil Nadu, 600099.
The corporate identification number (CIN) of Kinesis Pharmaceuticals Private Limited is U24231TN1994PTC027081 and the company number is 027081 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2023, the revenue trend for Kinesis Pharmaceuticals Private Limited has fallen by -15.45%.
As Per 2023 financial reports, 33 employees are currently employed by Kinesis Pharmaceuticals Private Limited.
The financial reports for the fiscal year 2023 indicates that The net worth of Kinesis Pharmaceuticals Private Limited has experienced an upsurge of 25.46%.
As per the financial statements for fiscal Year 2023, The total open charges for Kinesis Pharmaceuticals Private Limited amount to ₹ 0.60 M.
The most recent Balance Sheet for Kinesis Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
SS
AV
BS